Masai Kyohei, Iwashita Yukio, Tominaga Masayuki, Hirano Seitaro, Shibata Kohei, Matsumoto Toshifumi, Sasaki Atsushi, Ohta Masayuki, Kitano Seigo
Dept of Surgery I, Oita University Faculty of Medicine.
Gan To Kagaku Ryoho. 2004 Aug;31(8):1261-3.
Chemokines represent a large family of polypeptide signaling molecules that are notable for their role in chemotaxis, leukocyte homing, and directional migration. Recent observations have indicated that the expression of chemokine receptors on cancer cells may play a role in tumor progression and metastasis. In this study, the expression of mRNA for chemokine receptors in various human tumor cell lines was analyzed by multiplex-polymerase chain reaction (M-PCR). Strong expression of CCR6 mRNA in 3 of 3 hepatoma cell lines was observed. In the 3 pancreatic cancer cell lines, no specific expression of chemokine receptors was observed. Raji (lymphoma cell line) strongly expressed CCR7 and CXCR4. We further investigated CCR6 mRNA expression in these cell lines by real-time quantitative-PCR. Similar results were obtained by both the PCR methods. Because human liver constitutively express liver and activation-regulated chemokine (specific ligand for CCR6), hepatoma cells may selectively root and spread in the liver. Strong CCR7 and CXCR4 expressions in the lymphoma cell may explain the organ specificity of lymphoma for lymphoid organs as well. These findings probably indicate that some cancer cells have organ specificity via expression of chemokine receptors.
趋化因子是一大类多肽信号分子,因其在趋化作用、白细胞归巢和定向迁移中的作用而闻名。最近的观察表明,癌细胞上趋化因子受体的表达可能在肿瘤进展和转移中发挥作用。在本研究中,通过多重聚合酶链反应(M-PCR)分析了各种人类肿瘤细胞系中趋化因子受体的mRNA表达。在3种肝癌细胞系中均观察到CCR6 mRNA的强表达。在3种胰腺癌细胞系中,未观察到趋化因子受体的特异性表达。Raji(淋巴瘤细胞系)强烈表达CCR7和CXCR4。我们通过实时定量PCR进一步研究了这些细胞系中CCR6 mRNA的表达。两种PCR方法均获得了相似的结果。由于人类肝脏组成性表达肝脏和激活调节趋化因子(CCR6的特异性配体),肝癌细胞可能在肝脏中选择性地扎根和扩散。淋巴瘤细胞中CCR7和CXCR4的强表达也可能解释了淋巴瘤对淋巴器官的器官特异性。这些发现可能表明,一些癌细胞通过趋化因子受体的表达具有器官特异性。